NEW YORK, Jan. 22, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Transdermal Drug Patches to 2020
http://www.reportlinker.com/p01941669/Transdermal-Drug-Patches-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication
Greystone Research Associates is pleased to announce the publication of a new market study. Transdermal Drug Patches to 2020: Products, Therapeutics, Markets, and Forecasts is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the drug delivery sector. The study is designed to provide drug company decision makers, drug delivery developers, patch designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for Transdermal patches Provider organization business managers, healthcare administrators and investors will also benefit from this study.
Wearable Drug Systems and the Growth of Chronic Disease Management
Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for drug patches is being driven by several factors – factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2020.
Feature Summary
- Analyzes and evaluates current transdermal drug patch markets and products and assesses the market potential for existing and probable future products - Analyzes patch designs, technologies and patch development issues - Profiles patch manufacturers and third-party transdermal supply chain companies - Provides detailed assessments of more than forty patch products in more than a dozen product categories - Provides market data and forecasts to 2020 - Profiles transdermal drug patch product providers, their product development activity, and strategies - Evaluates the impact of economic, technology, and regulatory factors
Highlights
- Analyzes patch designs, technologies and patch development issues
- Provides assessments of transdermal drug patch products in two dozen key market segments
- Provides market data and forecasts to 2020
- Profiles patch manufacturers, their product development activities and strategies
Executive Summary
The Market Opportunity
Transdermal Drug Delivery Dynamics
Demand Drivers
Competitive Landscape
Factors Limiting Growth
Pharmacokinetics & Dosage Forms
Patch Manufacturing Dynamics
Patch Manufacturing Company Profiles
Product Analysis – FDA-Approved Drugs Delivered via Transdermal Patches
Alkaloids
Androgens
Antidepressants
Antiemetics
Antispasmodics
CNS Stimulants
Cholinesterase Inhibitors
Dopamine Agonists
Hormone Replacement
Hypotensive Agents
Local Anesthetics
NSAIDs
Opioid Analgesics
Progestrins
Trinitrates
Market Analysis – Transdermal Drug Patch Therapeutics
ADHD
Addiction
Contraception
Cardiovascular/Angina
Depression
Hormone Replacement Therapy
Hypertension
Motion Sickness
Neurology
Osteoporosis
Pain Management
Market Factors
Regulatory Issues
IP and Expiring Patents
Rx-to-OTC Switching
Patient Compliance and Ease of Use
Healthcare Economics
Profiles of Market Participants
To order this report: Transdermal Drug Patches to 2020 http://www.reportlinker.com/p01941669/Transdermal-Drug-Patches-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article